UNSPSC 51441801: Cosyntropin/mannitol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DX900. This VA Drug Class (DX900) classifies this compound as belonging to the group DIAGNOSTICS, OTHER.

UNSPSC 51441801 Cosyntropin/mannitol is a Commodity code that shows little relevant recent activity under its nominal scope. The two most recent state and local opportunities tagged to this code do not involve the pharmaceutical products the code nominally describes. Broward County Aviation Department posted an RFI on June 25, 2026, seeking maintenance services for proprietary Rapiscan X-ray inspection systems — a capital equipment service, not a pharmaceutical — with responses due July 28, 2026. Pasco County, Florida issued an RFQ on June 3, 2026, for large copper sulfate crystals and liquid copper sulfate on an as-needed basis, with proposals due June 26, 2026 — industrial chemicals, not pharmaceutical agents. Neither opportunity aligns with cosyntropin (a synthetic adrenocorticotropic hormone) or mannitol (an osmotic diuretic) procurement.

The geographic spread represented in recent records is limited to Florida (Broward County and Pasco County), but this reflects the mismatch between the code's pharmaceutical scope and the actual work being solicited. State and local procurement offices do not appear to be using this code for its intended purpose at present, making it unsuitable as a reliable indicator of near-term pharmaceutical opportunity in state and local markets.